Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia.
Begum H, Neto AS, Alliegro P, Broadley T, Trapani T, Campbell LT, Cheng AC, Cheung W, Cooper DJ, Erickson SJ, French CJ, Litton E, McAllister R, Nichol A, Palermo A, Plummer MP, Rotherham H, Ramanan M, Reddi B, Reynolds C, Webb SA, Udy AA, Burrell A. Begum H, et al. Among authors: campbell lt. Med J Aust. 2022 Oct 3;217(7):352-360. doi: 10.5694/mja2.51590. Epub 2022 Jun 9. Med J Aust. 2022. PMID: 35686307 Free PMC article.
Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic.
Burrell AJ, Pellegrini B, Salimi F, Begum H, Broadley T, Campbell LT, Cheng AC, Cheung W, Cooper DJ, Earnest A, Erickson SJ, French CJ, Kaldor JM, Litton E, Murthy S, McAllister RE, Nichol AD, Palermo A, Plummer MP, Ramanan M, Reddi BA, Reynolds C, Trapani T, Webb SA, Udy AA. Burrell AJ, et al. Among authors: campbell lt. Med J Aust. 2021 Jan;214(1):23-30. doi: 10.5694/mja2.50883. Epub 2020 Dec 15. Med J Aust. 2021. PMID: 33325070
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Arabi YM, Gordon AC, Derde LPG, Nichol AD, Murthy S, Beidh FA, Annane D, Swaidan LA, Beane A, Beasley R, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buxton M, Buzgau A, Cheng A, De Jong M, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Fowler R, Girard TD, Goligher EC, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Huang DT, King AJ, Lamontagne F, Lawler PR, Lewis R, Linstrum K, Litton E, Lorenzi E, Malakouti S, McAuley DF, McGlothlin A, Mcguinness S, McVerry BJ, Montgomery SK, Morpeth SC, Mouncey PR, Orr K, Parke R, Parker JC, Patanwala AE, Rowan KM, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Tong SYC, Turgeon AF, Turner AM, Van de Veerdonk FL, Zarychanski R, Green C, Berry S, Marshall JC, McArthur C, Angus DC, Webb SA; REMAP-CAP Investigators. Arabi YM, et al. Intensive Care Med. 2021 Aug;47(8):867-886. doi: 10.1007/s00134-021-06448-5. Epub 2021 Jul 12. Intensive Care Med. 2021. PMID: 34251506 Free PMC article. Clinical Trial.
Optimising a targeted test reduction intervention for patients admitted to the intensive care unit: The Targeted Intensive Care Test Ordering Cluster Trial intervention.
Litton E, Atkinson H, Anstey J, Anstey M, Campbell LT, Forbes A, Hahn R, Hooper K, Kasza J, Knapp S, McGain F, Ngyuen N, Pilcher D, Reddi B, Reid C, Robinson S, Thompson K, Webb S, Young P. Litton E, et al. Among authors: campbell lt. Aust Crit Care. 2021 Sep;34(5):419-426. doi: 10.1016/j.aucc.2020.11.003. Epub 2021 Jan 30. Aust Crit Care. 2021. PMID: 33526330
Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial.
Shehabi Y, Serpa Neto A, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Kadiman SB, McArthur CJ, Reade MC, Seppelt IM, Takala J, Wise MP, Webb SA; SPICE III Study Investigators. Shehabi Y, et al. Intensive Care Med. 2021 Apr;47(4):455-466. doi: 10.1007/s00134-021-06356-8. Epub 2021 Mar 8. Intensive Care Med. 2021. PMID: 33686482 Free PMC article. Clinical Trial.
Incident haemodialysis and outcomes in the Top End of Australia.
Hughes JT, Majoni SW, Barzi F, Harris TM, Signal S, Lowah G, Kapojos J, Abeyaratne A, Sundaram M, Goldrick P, Jones SL, McFarlane R, Campbell LT, Stephens D, Cass A. Hughes JT, et al. Among authors: campbell lt. Aust Health Rev. 2020 Apr;44(2):234-240. doi: 10.1071/AH18230. Aust Health Rev. 2020. PMID: 30995950
Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in Australia.
Burrell AJC, Neto AS, Broadley T, Trapani T, Begum H, Campbell LT, Cheng AC, Cheung W, Cooper DJ, Erickson SJ, French CJ, Kaldor JM, Litton E, Murthy S, McAllister RE, Nichol AD, Palermo A, Plummer MP, Ramanan M, Reddi BAJ, Reynolds C, Webb SA, Udy AA; SPRINT SARI Australia Investigators. Burrell AJC, et al. Among authors: campbell lt. Crit Care Resusc. 2023 Oct 18;23(3):308-319. doi: 10.51893/2021.3.OA8. eCollection 2021 Sep 6. Crit Care Resusc. 2023. PMID: 38046076 Free PMC article.
Frequency modulated free electron laser.
Campbell LT, McNeil BWJ. Campbell LT, et al. Opt Express. 2019 Mar 18;27(6):8792-8799. doi: 10.1364/OE.27.008792. Opt Express. 2019. PMID: 31052691 Free article.
22 results